Business Description
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s lead clinical program is EB-101, its investigational autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa in Phase 3 development. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need.
Company Info
Address:
6555 Carnegie Avenue
4th Floor
Cleveland, OH 44103
Industry Classifications
Sector:
Healthcare
Industry:
Biotechnology
NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC:
Pharmaceutical Preparations (2834)